Sugi Predict

Sugi Predict / Compounds / SCHEMBL1827122

SCHEMBL1827122

SCHEMBL1827122

Cc1cccc(CC(O)C(=O)O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM6B O15054 1/20 0.54
▸ CTBP2 P56545 1/20 0.49
▸ PPARG P37231 1/20 0.46
▸ PPARA Q07869 1/20 0.46
▸ CTSB P07858 3/20 0.45
▸ POLB P06746 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CTSL P07711 1/20 0.44
▸ CTSS P25774 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PTPN7 P35236 1/20 0.44
▸ BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30738540 1.00 KDM6B (0.54) KDM6BCTBP2PPARGPPARACTSB
SCHEMBL31320962 1.00 KDM6B (0.54) KDM6BCTBP2PPARGPPARACTSB
SCHEMBL31320968 1.00 KDM6B (0.54) KDM6BCTBP2PPARGPPARACTSB
SCHEMBL2165111 1.00 KDM6B (0.54) KDM6BCTBP2PPARGPPARACTSB
SCHEMBL4950625 1.00 KDM6B (0.54) KDM6BCTBP2PPARGPPARACTSB
SCHEMBL7440986 0.85 CTBP2 (0.51) CTBP2PPARGPPARACTSBPOLB
SCHEMBL14016346 0.84 POLB (0.47) CTBP2CTSBPOLBALDH1A1TP53
SCHEMBL7381207 0.84 CYP1A2 (0.62) CTBP2PPARGPPARA
SCHEMBL19295495 0.82 CTBP2 (0.49) CTBP2PPARGPPARACTSBPOLB
SCHEMBL4469435 0.82 CTBP2 (0.49) CTBP2PPARGPPARACTSBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117339390-A Synergistic extraction system and extraction process for extracting and separating boron isotopes 中国科学院过程工程研究所 2024-01-05 — — CN claimed
EP-3914256-B1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES INC (US) 2024-05-29 — — EP disclosed
CN-117339390-A Synergistic extraction system and extraction process for extracting and separating boron isotopes 中国科学院过程工程研究所 2024-01-05 — — CN disclosed
US-11773101-B2 GPR35 modulators PROMETHEUS BIOSCIENCES, INC. (US) 2023-10-03 — — US disclosed
US-20210380590-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. 2021-12-09 — — US disclosed
EP-3914256-A1 GPR35 MODULATORS Prometheus Biosciences, Inc. (US) 2021-12-01 — — EP disclosed
CN-113631168-A GPR35 modulators 普罗米修斯生物科学公司 2021-11-09 — — CN disclosed
US-11053251-B2 GPR35 modulators PROMETHEUS BIOSCIENCES, INC. (US) 2021-07-06 — — US disclosed
WO-2020154492-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. (US) 2020-07-30 — — WO disclosed
US-20200239476-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. 2020-07-30 — — US disclosed
US-7479488-B2 Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-20 — — US disclosed
EP-1578910-A4 NITRILASES VERENIUM CORP (US) 2008-06-04 — — EP disclosed
US-20060252750-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-11-09 — — US disclosed
EP-1578910-A2 NITRILASES DIVERSA CORPORATION (US) 2005-09-28 — — EP disclosed
EP-1283825-B1 N-SUBSTITUTED PEPTIDYL NITRILES AS CYSTEINE CATHEPSIN INHIBITORS NOVARTIS AG (CH) 2005-09-14 — — EP disclosed
US-6812237-B2 (ARYLAMINOACEAMIDO)ACETONITRILE DERIVATIVES NOVARTIS AG (CH) 2004-11-02 — — US disclosed
US-20030158256-A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors NOVARTIS AG (CH) 2003-08-21 — — US disclosed
EP-1283825-A1 N-SUBSTITUTED PEPTIDYL NITRILES AS CYSTEINE CATHEPSIN INHIBITORS Novartis AG (CH) 2003-02-19 — — EP disclosed
WO-2003000840-A2 NITRILASES DIVERSA CORPORATION (US) 2003-01-03 — — WO disclosed
WO-2001087828-A1 N-SUBSTITUTED PEPTIDYL NITRILES AS CYSTEINE CATHEPSIN INHIBITORS NOVARTIS AG (CH) 2001-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158256-A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors CTSS, CTSV, CTSF KDM6B 2226/4885CTBP2 1017/4885PPARG 2607/4885
US-20210380590-A1 GPR35 MODULATORS GPR35, GPR55, GPR65 KDM6B 4475/4885CTBP2 1204/4885PPARG 34/4885
US-11053251-B2 GPR35 modulators GPR35, GPR55, GPR65 KDM6B 4475/4885CTBP2 1204/4885PPARG 34/4885
US-11773101-B2 GPR35 modulators GPR35, GPR55, GPR65 KDM6B 4475/4885CTBP2 1204/4885PPARG 34/4885
US-20060252750-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions CALCRL, CALCR, CALCA KDM6B 4577/4885CTBP2 2673/4885PPARG 2294/4885
US-20200239476-A1 GPR35 MODULATORS GPR35, GPR55, GPR65 KDM6B 4475/4885CTBP2 1204/4885PPARG 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.